Novavax, COVID-19 and influenza vaccine

Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales
Novavax cut its annual revenue forecast on Tuesday, citing lower-than-expected sales of its COVID-19 vaccine, ahead of handing over the rights to sell the shot to Sanofi. The U.S. vaccine maker now expects between $175 million and $225 million for full-year sales of its COVID vaccine,
FDA Lifts Clinical Hold On Novavax COVID-19-Influenza Combo Vaccine Candidate; Stock Up
(RTTNews) - Novavax, Inc. (NVAX) Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine candidates. Novavax shares were up more than 13 percent in pre-market.
Novavax to Move Forward With Covid-19-Flu Vaccine After FDA Lifts Clinical Hold -- Update
Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, Sanofi will have the sole right to use Novavax's existing Covid-19 vaccine in combination with its own flu vaccine.
FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine
The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused trials.
Novavax sees weak Covid vaccine sales, convinced Sanofi can do better
Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals and a pipeline of new vaccines it's now evaluating for R&D.
Business Insider1d
Novavax Advances Vaccine Strategy Amid Financial Shifts
In its recent third-quarter 2024 earnings report, Novavax highlighted significant advancements in its vaccine portfolio, including the removal of a clinical hold by the U.S. FDA on its ...
Benzinga.com3d
FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial
Earlier this month, Novavax and the U.K. Health Security Agency, representing the U.K. Secretary of State for Health and Social Care, signed a Termination and Settlement Agreement and an amendment ...
Yahoo Finance26d
How Bad Is This News for Novavax?
How bad is this news for Novavax? Let's find out. Image source: Getty Images. Novavax has brought together its coronavirus vaccine with its expertise in flu to create a candidate that would ...
pharmaphorum15d
Novavax's COVID-19 shot effective against UK strain
Novavax’s COVID-19 vaccine could ... Hancock said the vaccine would be a “significant boost” to the UK’s vaccination programme. He added: “The NHS stands ready to roll this vaccine ...
FiercePharma8d
Novavax coughs up $123.8M to settle COVID vaccine supply dispute with UK
Novavax has inked another settlement for a past COVID-19 vaccine supply ... year after Sanofi shelled out $500 million up front to partner on Nuvaxovid. In other vaccine supply settlements ...
AOL29d
Here’s What You Need to Know About Getting the New 2024 COVID Vaccine
There are three different COVID vaccines to choose from this season: two mRNA vaccines from Pfizer and Moderna, and a protein-based vaccine from Novavax ... points out that COVID-19 ...
Wall Street Journal23d
Novavax Stock Plunges After FDA Pauses Covid, Flu Vaccine Trials
Novavax shares tumbled after the Food and Drug Administration put a clinical hold on its testing applications for a combined Covid-flu vaccine and standalone flu inoculation due to safety ...
The Star18d
Singapore to roll out updated Covid-19 vaccines from Monday (Oct 28)
SINGAPORE (Bernama): Singapore’s Health Ministry (MOH) will roll out the ... of severe Covid-19, including seniors and medically vulnerable individuals. "The updated Covid-19 vaccines ...
Hosted on MSN3d
Novavax to Report Q3 Earnings: Here's What to Expect
Novavax NVAX is scheduled to report third-quarter 2024 earnings on Nov. 12, before the opening bell. In the last reported ...